Minster Pharmaceuticals plc

Minster Pharmaceuticals plc

Minster Pharmaceuticals plc, through its subsidiary, Minster Research Limited, develops pharmaceutical compounds for the treatment of neurological and psychiatric conditions in the United Kingdom. Its products pipeline comprises Tonabersat, which is in Phase IIb clinical trial for the prevention and treatment of migraine; and Sabcomeline, a Phase IIa clinical trial product for the management of cognitive decline and negative symptoms in schizophrenia. The company is based in Saffron Walden, the United Kingdom.

Contact Details

Office Address

Minster Pharmaceuticals plc
107-111 Fleet Street, London, UK EC4A2AB
Phone: +44-207-936-9921
Fax: +44-207-936-9100

Executives

Chairman and Interim Chief Executive

John Russell

CFO and Director

Karl Keegan

Business Reviews for Minster Pharmaceuticals plc

Related Companies